Nilank Shah MD | Medicine | Best Researcher Award

Dr. Nilank Shah MD | Medicine | Best Researcher Award

Course Director and Professor, Touro College of Osteopathic Medicine, United States

An accomplished medical professional with extensive expertise in pharmacology and toxicology, this individual has dedicated their career to advancing medical education and research. They have held various prestigious positions, including Principal Investigator at TouroCOM, where they focus on organ preservation and therapeutic solutions. Their commitment to innovation in teaching methodologies and multidisciplinary research reflects a deep passion for both education and health science. ๐ŸŒŸ

Publication Profile

Google Scholar

Education

Graduating with an MBBS from MPS Medical College & Hospital in India, they further specialized with an MD in Pharmacology and Applied Therapeutics from the same institution. Their academic journey continued with an MS in Pharmacology & Toxicology from Long Island University, USA, followed by a Post-Doctoral Fellowship in Physiology and Pharmacology at the State University of New York. Additionally, they completed certificate programs in Food & Nutrition and Nutrition & Care with first-class honors from Indira Gandhi National University. ๐ŸŽ“

Experience

With a robust background in both clinical practice and academia, this professional has successfully integrated teaching with research. They have developed special methodologies and new pedagogies that enhance the learning experience for students in health sciences. Their role as a Principal Investigator on multiple funded research projects at TouroCOM highlights their ability to lead impactful studies in the field. ๐Ÿ’ผ

Research Focus

Their research primarily concentrates on organ preservation solutions and the therapeutic effectiveness of innovative oxygen carriers in cardiac care. This work exemplifies their commitment to advancing healthcare through rigorous scientific investigation, bridging clinical applications with cutting-edge research in pharmacology and toxicology. ๐Ÿ”ฌ

Awards and Honors

This individual has received numerous accolades for their contributions to medical research and education, including several funded research grants as Principal Investigator. Their recognition underscores their role as a leader in the field and their dedication to improving health outcomes through science and education. ๐Ÿ†

Publication Top Notes

“Organ Preservation Solution: A Multidisciplinary Approach” – Journal of Clinical Pharmacology (2023) Cited by 30 articles

“Therapeutic Effectiveness of OxyVita Hemoglobin Based Oxygen Carrier” – Cardiology Research (2022) Cited by 25 articles

“Advancements in Organ Transplantation: A Review” – American Journal of Transplantation (2021) Cited by 40 articles

“Innovative Teaching Methodologies in Medical Education” – Medical Education Online (2020) Cited by 15 articles

 

Miguel Virseda-Chamorro | Medicine and Dentistry | Best Researcher Award

Dr. Miguel Virseda-Chamorro | Medicine and Dentistry | Best Researcher Award

Dr. Miguel Virseda-Chamorro, Hospital Nacional de paraplรฉjicos, Spain

Dr. Miguel Virseda-Chamorro is a distinguished urologist with extensive expertise in urodynamics and pelvic floor disorders. He earned his MD from the University of Valencia in 1981 and specialized in Urology at Gรณmez Ulla Hospital in 1990. He holds a PhD, awarded cum laude in 1992, and completed further education in Health Sciences Statistics. Dr. Virseda is a Fellow of the European Board of Urology and has contributed to major scientific journals. Recognized with several prestigious awards, his research has impacted functional urology and neurogenic bladder treatment. He is fluent in multiple languages and an active member of several urological societies. ๐Ÿฅ๐Ÿงฌ๐Ÿ“Š

Publication Profile

Scopus

Orcid

Academic Formation and Specializations

Dr. Virseda-Chamorro has an impressive academic trajectory, beginning with a Licenciatura in Medicine and Surgery from the University of Valencia (1981) and multiple specialized courses in Urology and Medical Aeronautics. He has also pursued advanced degrees, including a Master in Health Sciences Design and Statistics (2001), which supports his clinical research. His PhD in Urology, awarded with distinction, further underscores his expertise in the field.

Awards and Distinctions

His outstanding contributions have been recognized through several prestigious awards, such as the Best Doctoral Thesis Awards (1992, 1995), and multiple honors from the Spanish Urology Association for his groundbreaking research. These recognitions validate his impact on the field of urology, particularly in areas like urodynamic models and pelvic prolapse treatment.

Teaching and Clinical Trials

Dr. Virseda-Chamorro has also made significant contributions to medical education, leading various courses on pelvic floor treatment and urodynamic pediatric pathologies. His participation in numerous clinical trials, such as evaluating the efficacy of beta-3 agonists for overactive bladder, shows his ongoing commitment to advancing medical knowledge and patient care.

Conclusion

Dr. Miguel Virseda-Chamorroโ€™s rich academic background, clinical expertise, significant research contributions, and numerous honors make him an ideal candidate for the Best Researcher Award. His dedication to both clinical practice and advancing scientific understanding in urology highlights his qualification for this prestigious recognition.

 

Publication Top Notes

  • Can We Differentiate Between Organic and Functional Bladder Outlet Obstruction in Males With Parkinson’s Disease? (2024)ย  ๐Ÿง ๐Ÿ“…
  • Factors Influencing Postoperative Overactive Bladder after Adjustable Trans-Obturator Male System Implantation for Male Stress Incontinence following Prostatectomy (2023) – 1 citation ๐Ÿ’‰๐Ÿ“…
  • Update on Adjustable Trans-Obturator Male System (ATOMS) for Male Incontinence after Prostate Cancer Surgery (2023) – 4 citations ๐Ÿฆ ๐Ÿ“…
  • ATOMS in Patients with Post-Prostatectomy Incontinence and Previously Treated Urethral Stricture or Bladder Neck Contracture (2022) – 6 citations ๐Ÿšป๐Ÿ“…
  • Functional Changes during the Voiding Phase in Men with Non-Neurogenic Detrusor Underactivity Undergoing Bladder Catheterization (2022)ย  ๐Ÿงฌ๐Ÿ“…
  • Compression or Obstruction: Analysis of the Function of ATOMS Based on Pre- and Postoperative Urodynamic Data (2022) – 4 citations ๐Ÿ› ๏ธ๐Ÿ“…
  • Urodynamics of Urinary Retention in Guillain-Barrรฉ Syndrome Post-Infection by SARS-CoV-2 (2022) – 1 citation ๐ŸŒ๐Ÿ“…
  • Influence of ATOMS Implant on the Voiding Phase of Patients with Post-Prostatectomy Urinary Incontinence (2022) – 3 citations ๐Ÿšฝ๐Ÿ“…
  • Prevalence and Risk Factors for Lower Urinary Tract Symptoms after Robotic Sacrocolpopexy (2021) – ๐Ÿค–๐Ÿ“…
  • Long-term Outcome of ATOMS for Stress Urinary Incontinence in the Iberian Multicentre Study (2020) – 17 citations ๐Ÿ“Š๐Ÿ“…

 

 

 

 

Ivan Medina | Health Professions | Best Researcher Award

Ivan Medina | Health Professions | Best Researcher Award

Prof Ivan Medina, Universidad de Mรกlaga, Spain

Prof. Ivan Medina-Porqueres is a distinguished expert in Physical Therapy with over 20 years of experience at the University of Malaga, where he teaches courses such as Musculoskeletal Assessment and Manual Therapy. He holds advanced master’s degrees in Sports Physiotherapy and Research in Sports & Physical Activity. With over 70 publications, his research focuses on clinical assessment, sports injuries, and innovative therapies like Platelet-Rich Plasma treatment. An active member of professional organizations, he frequently speaks at conferences, reflecting his commitment to advancing physiotherapy. Prof. Medina’s work significantly enhances clinical practice and patient care. ๐ŸŽ“๐Ÿฉบ๐Ÿ“šโœจ

Publication Profile

Google Scholar

Academic and Professional Background

Prof. Medina has over 20 years of experience in the field of Physical Therapy and has played a significant role in teaching courses like Musculoskeletal Assessment, Kinesiology, Anatomy, and Manual Therapy at the University of Malaga. His educational background, including advanced master’s degrees in Sports Physiotherapy, Manual Therapy, and Research in Sports & Physical Activity, establishes him as an expert in his field.

CAREER PROFILE

Experienced physical therapist with a rich academic and administrative background in university-based settings, actively involved in various sports disciplines since 1998. Demonstrates a proven ability to ensure safe, quality patient care while building productive teams and effectively managing administrative and financial tasks. Committed to achieving corporate objectives, with well-developed interpersonal skills that foster leadership in team-oriented environments. Current clinical expertise and recent publications enhance a contemporary approach to patient care, ensuring that practices remain relevant and effective. Prof. Ivan Medina-Porqueres continues to contribute positively to both academic and clinical landscapes. ๐Ÿฅ๐ŸŽ“๐Ÿ’ช๐Ÿ“ˆ

Research Focus

Prof. Ivan Medina-Porqueres focuses his research on the field of physiotherapy, with particular expertise in musculoskeletal injuries, sports rehabilitation, and innovative treatment modalities. His significant contributions include studies on the effectiveness of acupuncture, eccentric exercise therapy, and platelet-rich plasma in managing various conditions like shoulder impingement, osteoarthritis, and fibromyalgia. He emphasizes clinical assessment and therapeutic exercises for recovery training, addressing issues such as myofascial pain and pelvic floor health. Prof. Medina’s work is influential in advancing clinical practices and improving patient outcomes, solidifying his role as a key figure in contemporary physiotherapy research. ๐Ÿ‹๏ธโ€โ™‚๏ธ๐Ÿ“š๐Ÿ’‰๐Ÿ’ช

Publication Top Notes

Single-point acupuncture and physiotherapy for the treatment of painful shoulder: a multicentre randomized controlled trial

TENDร“N. Valoraciรณn y tratamiento en fisioterapia

Effectiveness of the eccentric exercise therapy in physically active adults with symptomatic shoulder impingement or lateral epicondylar tendinopathy: a systematic review

Anterior Cruciate Ligament Strain In Vivo: A Systematic Review

Physical examination tests for the diagnosis of femoroacetabular impingement. A systematic review

Manual de pruebas diagnosticas

En: Manual de pruebas diagnรณsticas

Conclusion

With his extensive experience, significant contributions to research, and dedication to education and community engagement, Prof. Ivan Medina-Porqueres is a highly deserving candidate for the Best Researcher Award. His work not only advances knowledge in physiotherapy but also enhances clinical practice and patient care.

Rasheedat Balogun | Obstetric Haemorrhage | Best Researcher Award

Dr. Rasheedat Balogun | Obstetric Haemorrhage | Best Researcher Award

Dr. Rasheedat Balogun, University College Hospital Ibadan/ Fertpromax Consult, Nigeria

Dr. Rasheedat Omolola Balogun ๐ŸŽ“ is a distinguished Consultant Gynaecologist and Fertility Specialist at Fertpromax Consult, Lagos, Nigeria. With an MB; BS from the University of Ibadan (2013), she excelled as the Best Graduating Student in Surgery. Dr. Balogun has received multiple accolades, including Overall Best Candidate and Best Female Candidate in Obstetrics & Gynaecology from the West African College of Surgeons (2020). Her research contributions include publications in prominent journals, focusing on pregnancy-related cases.

Publication profile

Orcid

Educational Background

Dr. Rasheedat Omolola Balogun holds a distinguished educational background in medicine and surgery. She earned her MB; BS degree from the University of Ibadan, College of Medicine, in 2013, where she graduated as the Best Graduating Student in Surgery. In 2020, she became a member of the West African College of Surgeons (MWACS) in Obstetrics and Gynaecology. Recently, in 2023, Dr. Balogun attained the Fellow of the Medical College of Obstetrics and Gynaecology (FMCOG) designation from the National Postgraduate Medical College of Nigeria. Her foundational education was completed at the Federal Government College, Ijanikin, Lagos, where she earned her WASSC in 2005. ๐Ÿ“šโœจ

 

Professional Experience

Dr. Rasheedat Omolola Balogun is a highly skilled Consultant Gynaecologist and Fertility Specialist at Fertpromax Consult in Gbagada, Lagos, since February 2024. Previously, she served as Chief Resident in Obstetrics and Gynaecology at University College Hospital (UCH), Ibadan, from November 2022 to October 2023. Dr. Balogun also held the position of Senior Resident in the Assisted Conception Unit (IVF) at UCH from December 2020 to October 2023 and completed her residency in Obstetrics and Gynaecology from 2017 to 2020. Her medical journey began as a House Officer at UCH (2013-2014), with roles as a Medical Officer at several hospitals, including Get-Well Hospital and TZ Hospital. ๐ŸŒŸ๐Ÿฅ

 

Awards and Honors

Dr. Rasheedat Omolola Balogun has received several prestigious awards in recognition of her outstanding contributions and achievements. In 2023, she was honored by University College Hospital (UCH), Ibadan, for her dedication and growth contributions to the hospital. She also earned the UCH Shalina Rising Star award, being recognized as one of the top six best residents’ dissertations and finishing as the first runner-up. Additionally, Dr. Balogun received the Professor Vincent Aimakhu Prize from the West African College of Surgeons in 2021 for being the best candidate in the 2020 membership examinations, along with the Eusebe Alihonou Prize for being the best female candidate. ๐ŸŒŸโœจ

 

Conclusion

Dr. Rasheedat Balogun embodies the qualities sought in a recipient of the Research for Best Researcher Award. Her exceptional educational achievements, extensive clinical experience, impactful research contributions, and recognition by peers demonstrate her unwavering commitment to the field of obstetrics and gynecology. She stands out as a candidate who not only contributes to medical science but also inspires future generations of healthcare professionals.

 

Publication Top Notes

  • A randomized controlled trial on the comparison of two doses of carbetocin with oxytocin for the prevention of postpartum hemorrhage (Concert Trial), Journal of Obstetrics and Gynaecology Research (2024) DOI: 10.1111/jog.16097 ๐Ÿฉบ
  • Assessment of anxiety and depression, and coping mechanisms during COVID-19 lockdown among pregnant women, Heliyon (2022) DOI: 10.1016/j.heliyon.2022.e10902 ๐Ÿ˜ท
  • Outcomes following cervical cerclage at the University College Hospital. A retrospective analysis, Conference paper (Year not specified) ๐Ÿ“„

Mahmoud Ramadan | Medicine and Dentistry | Outstanding Scientist Award

Assoc Prof Dr. Mahmoud Ramadan | Medicine and Dentistry | Outstanding Scientist Award

Associate Professor at College of Medicine, University of Sharjah, United Arab Emirates

Dr. Mahmoud Ramadan is an accomplished Clinical Associate Professor with extensive expertise in cardiovascular medicine and cardiology. He holds a Doctorate in Cardiovascular Medicine from Niigata University, Japan, and has been involved in various academic and clinical roles, currently serving at both the University of Sharjah in the UAE and Mansoura University in Egypt. With multiple certifications in cardiology and significant research experience, including participation in the global INTERHEART study, Dr. Ramadan has contributed numerous publications to esteemed journals. His proficiency in statistical analysis, languages, and various medical certifications underscores his dedication to advancing cardiovascular health and education.

Publication profile

Scopus Profileย 

Education Background

Dr. Mahmoud Ramadan holds an extensive educational background in the field of medicine, particularly in cardiovascular medicine. He earned his Doctorate Degree in Cardiovascular Medicine from Niigata University Graduate School of Medical and Dental Sciences in Japan, graduating in September 2008. His doctoral thesis focused on the “Impact of Percutaneous Coronary Intervention on the Levels of Interleukin-6 and C-Reactive Protein in the Coronary Circulation of Subjects with Coronary Artery Disease.” Prior to this, he completed his Masterโ€™s degree in Cardiology at Mansoura University, Egypt, where he graduated in May 2001, and his undergraduate degree, M.B.B.Ch., from the same institution in November 1995, graduating with honors. Additionally, Dr. Ramadan has pursued further professional development, obtaining various certifications, including MRCP (UK) and other specialized courses in areas such as echocardiography, abdominal ultrasonography, and atherosclerosis, thereby reinforcing his expertise in the medical field.

Research Experience

Dr. Mahmoud Ramadan has extensive research experience in cardiovascular medicine, evidenced by his impactful work as a Clinical Associate Professor and multiple roles in renowned medical institutions. He earned his PhD from Niigata University, Japan, where he explored the effects of percutaneous coronary interventions on inflammatory markers in patients with coronary artery disease. His involvement in the global “INTERHEART” study significantly contributed to understanding myocardial infarction risk factors across various populations. Dr. Ramadan has published numerous original research articles in prestigious journals, focusing on topics such as cardiac dysfunction, coronary disease, and inflammatory responses, showcasing his dedication to advancing cardiovascular science. Additionally, he has supervised both master’s and PhD students, further demonstrating his commitment to fostering future research talent in the field.

Teaching and Mentoring Experience

Dr. Mahmoud Ramadan has extensive teaching and mentoring experience in the field of cardiology and medicine. As an Associate Professor of Medicine at the University of Sharjah and the Faculty of Medicine at Mansoura University, he has contributed significantly to the education of medical students and residents. He has lectured on various topics in cardiology, sharing his expertise and fostering critical thinking among students. Additionally, Dr. Ramadan has supervised numerous master’s and PhD students, guiding them through their research projects and dissertations, which demonstrates his commitment to nurturing the next generation of medical professionals. His role as an AHA-certified instructor in Advanced Cardiovascular Life Support (ACLS) and Basic Life Support (BLS) further underscores his dedication to teaching practical skills that are essential in clinical settings. Through his mentorship and teaching, he has played a vital role in shaping the educational landscape in cardiology, emphasizing the importance of both theoretical knowledge and hands-on experience.

Work Experience

Dr. Mahmoud Ramadan has an extensive work experience in the field of cardiology and medicine, spanning over two decades. He currently serves as an Associate Professor of Medicine in the Clinical Sciences Department at the University of Sharjah, UAE, and holds a similar position at Mansoura University in Egypt. His professional journey began as a House Officer at Mansoura University Hospitals, followed by various roles including Resident Physician, Assistant Lecturer, and Lecturer in Cardiology at Mansoura University. Throughout his career, he has engaged in advanced clinical training in Japan and contributed significantly to teaching, supervision, and research in cardiovascular medicine. Additionally, Dr. Ramadan is involved in multiple professional certifications, training programs, and has contributed to several international collaborative studies, showcasing his commitment to advancing medical knowledge and practice in cardiology.

Awards, Honours & Certificates

Dr. Mahmoud Ramadan has received several prestigious awards and honors throughout his academic and professional career. Notably, he was selected as a representative of Mansoura University in the global INTERHEART study, which was published in The Lancet. He also earned the esteemed Japanese Government Monbu-Kagakusho Scholarship for his PhD in Cardiology from Niigata University. In addition, Dr. Ramadan was recognized as a Young Investigator Award Finalist at the 22nd Annual Meeting of the Japanese Section of the International Society of Heart Research. His accolades include the EJISST Award at the First Egypt-Japan International Symposium on Science and Technology and the JSPS Post-Doctoral Fellowship from the Japan Society for the Promotion of Science in 2008. His commitment to continued education is evidenced by his completion of various certifications, including in mechanical ventilation and echocardiography, as well as his membership in several distinguished medical associations.

Publication Top Notes

  • Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990โ€“2021: a systematic analysis for the Global Burden of Disease Study 2021
    • Authors: Brauer, M., Roth, G.A., Aravkin, A.Y., Murray, C.J.L., Gakidou, E.
    • Year: 2024
    • Citations: 66
  • Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990โ€“2021: a systematic analysis for the Global Burden of Disease Study 2021
    • Authors: Ferrari, A.J., Santomauro, D.F., Aali, A., Vos, T., Murray, C.J.L.
    • Year: 2024
    • Citations: 107
  • Targeting inflammatory signaling pathways with SGLT2 inhibitors: Insights into cardiovascular health and cardiac cell improvement
    • Authors: Alsereidi, F.R., Khashim, Z., Marzook, H., Ramadan, M.M., Saleh, M.A.
    • Year: 2024
    • Citations: 4
  • Global, regional, and national burden of upper respiratory infections and otitis media, 1990โ€“2021: a systematic analysis from the Global Burden of Disease Study 2021
    • Authors: Sirota, S.B., Doxey, M.C., Dominguez, R.-M.V., Murray, C.J.L., Kyu, H.H.
    • Year: 2024
    • Citations: 1
  • Alchemilla vulgaris modulates isoproterenol-induced cardiotoxicity: interplay of oxidative stress, inflammation, autophagy, and apoptosis
    • Authors: Anajirih, N., Abdeen, A., Taher, E.S., Ramadan, M.M., Habotta, O.A.
    • Year: 2024
    • Citations: 0

Conclusion

Dr. Mahmoud Ramadan exemplifies the qualities of an outstanding researcher in cardiovascular medicine. His strong academic background, extensive research contributions, and clinical expertise make him a deserving candidate for the Best Researcher Award. By focusing on expanding his research scope, increasing outreach, diversifying research methodologies, and embracing innovative trends, he can further enhance his impact in the field. Awarding him this recognition would not only honor his past contributions but also encourage future advancements in cardiovascular research and patient care.

Mohamed Hizam Mohamed Noor | Wastewater Treatment | Best Researcher Award

Dr. Mohamed Hizam Mohamed Noor | Wastewater Treatment | Best Researcher Award

Dr. Mohamed Hizam Mohamed Noor, Universiti Teknologi Malaysia, Malaysia

Dr. Mohamed Hizam Mohamed Noor is a dedicated researcher in Environmental Engineering, having earned his PhD from Universiti Teknologi Malaysia. His doctoral thesis focused on utilizing Moringa Oleifera seed protein for wastewater treatment. Prior to this, he completed his Master’s with top honors, recognized as the Best Postgraduate Student. Currently, Dr. Hizam is a postdoctoral researcher at the Research Management Centre, Universiti Teknologi Malaysia. His innovative projects have garnered awards, including the Gold Award at the International Innovation & Invention Competition 2024. He is committed to advancing sustainable solutions for environmental challenges. ๐ŸŒฑ๐Ÿ†๐Ÿ“š

Publication profile

Google Scholar

Orcid


Education and Academic Qualification

Dr. Mohamed Hizam Mohamed Noor holds a Doctorate in Environmental Engineering from Universiti Teknologi Malaysia, where his thesis focused on the “Utilization of Moringa Oleifera Seed Protein in the Fabrication of Magnetic Cationic Starch Flocculant for Palm Oil Mill Effluent Treatment.” He also earned a Master’s degree with a perfect 4.00 GPA and received the Best Postgraduate Student Award for his work on “Synthesis and Application of Polyacrylamide Grafted Magnetic Cellulose Flocculant for Wastewater Treatment.” Currently a postdoctoral researcher, Dr. Hizam is dedicated to advancing sustainable solutions for environmental challenges. ๐Ÿ†๐Ÿ“š

 

Professional Experience and Contributions ๐ŸŒŸ

Dr. Mohamed Hizam Mohamed Noor has a robust professional background in environmental engineering. He serves as a postdoctoral researcher at the Research Management Centre, Universiti Teknologi Malaysia, since July 2023. He also contributes as an external panel member for final year project presentations at Universiti Teknologi MARA, scheduled for July 2024. In May 2023, he was an invited jury member for the International Virtual Expo of Innovation Product and System Design. Additionally, Dr. Hizam took on the role of secretary for a webinar on thesis content at the Postgraduate Student Society in 2022, showcasing his commitment to academic excellence. ๐ŸŽ“๐ŸŒฟ

 

Research Innovation Achievements ๐Ÿ†

Dr. Mohamed Hizam Mohamed Noor has showcased exceptional innovation in various competitions. At the 26th Industrial Art and Technology Exhibition (INATEX) 2024, he presented his project, FuelX CaZeo: Revolutionizing the Future of Eco-Fuel Production, earning a Certificate of Participation on October 2-3, 2024. He also secured the Gold Award and the Best of the Best Award in the Agriculture, Environment, and Renewable Energy category at the International Innovation & Invention Competition (IIICE) 2024 for his project STARPRO Flocculant, held on August 5, 2024. Furthermore, he was awarded a Gold Award at the International Virtual Expo of Innovation Product and System Design 2023 for the same project on June 23, 2023, solidifying his impact in environmental engineering. ๐ŸŒฑโœจ

Conclusion

Dr. Mohamed Hizam Bin Mohamed Noor possesses a robust combination of academic achievements, impactful research, and professional involvement that makes him an exemplary candidate for the Best Researcher Award. His commitment to addressing environmental challenges through innovative solutions further strengthens his suitability for this recognition.

Publication Top Notes

  • Assessing the effectiveness of magnetic nanoparticles coagulation/flocculation in water treatment: a systematic literature review – Cited by 53 (2021) ๐Ÿ“š
  • Synthesis and Application of Polyacrylamide Grafted Magnetic Cellulose Flocculant for Palm Oil Wastewater Treatment – Cited by 38 (2020) ๐ŸŒŠ
  • Aspirin Adsorption onto Activated Carbon Derived from Spent Tea Leaves: Statistical Optimization and Regeneration Study – Cited by 28 (2021) ๐Ÿต
  • Optimization of sonication-assisted synthesis of magnetic Moringa oleifera as an efficient coagulant for palm oil wastewater treatment – Cited by 18 (2021) ๐ŸŒฟ
  • Synthesis of magnetic cellulose as flocculant for pre-treatment of anaerobically treated palm oil mill effluent – Cited by 18 (2018) ๐Ÿ”ฌ
  • Moringa oleifera extract as green coagulant for POME Treatment: Preliminary studies and sludge evaluation – Cited by 17 (2021) ๐ŸŒฑ
  • Response Surface Optimization of Ultrasoundโ€Assisted Extraction of Sago Starch From Sago Pith Waste – Cited by 9 (2021) ๐Ÿš
  • Starch engineered with Moringa oleifera seeds protein crosslinked Fe3O4: A synthesis and flocculation studies – Cited by 7 (2021) โš—๏ธ
  • Microwave-vs Ultrasonic-synthesis of magnetic Moringa oleifera coagulant for the reduction of chemical oxygen demand in palm oil wastewater – Cited by 6 (2021) ๐Ÿ’ง
  • Phytotoxicity and Cost-effectiveness Analysis of Palm Oil Wastewater Treated with Magnetic Cationic Starch Flocculant – Cited by 5 (2022) ๐Ÿ’ฐ

Hong De Sa | Medicine and Dentistry | Women Researcher Award

Hong De Sa | Medicine and Dentistry | Women Researcher Award

Dr Hong De Sa, OHSU, United States

Based on Dr. Hong De Sa’s impressive background, I believe he is a strong candidate for the Women Researcher Award. Here are key points that highlight his qualifications:

Publication profile

Scopus

Education and Training

Dr. De Sa is currently pursuing a Hematology and Oncology Fellowship at Oregon Health & Science University, with a robust foundation from a Combined Internal Medicine and Pediatric Residency at Case Western Reserve University. His academic journey includes a Doctor of Medicine from Drexel University and a Bachelor of Arts in Neurobiology from Harvard University, showcasing a commitment to both medical excellence and interdisciplinary understanding.

Leadership and Experience

As Chief Fellow for the 2024-2025 academic year, Dr. De Sa demonstrates exceptional leadership in his current role in adult hematology and oncology. His participation in the Human Investigations Program further indicates his dedication to clinical and translational research, equipping him with vital skills in biostatistics, scientific writing, and research ethics.

Research Contributions

Dr. De Sa’s research focuses on critical areas within hematology and oncology, particularly malignant hematology and acute lymphoblastic leukemia. His publication on novel biomarkers in ALL has added significant value to the field. Furthermore, his involvement in presentations at prestigious conferences illustrates his active engagement in advancing knowledge and practices within his specialty.

Awards and Recognition

Dr. De Sa’s recognition includes the 2024 Research Training Award for Fellows from the American Society of Hematology, reflecting his potential for impactful research. His previous honors, such as the Byron R. Wien Scholarship at Harvard, indicate a long-standing commitment to service and academic excellence.

Community Engagement and Service

His service-oriented mindset is exemplified by awards recognizing his contributions to health outreach and public service initiatives during his educational journey, underscoring his dedication to improving community health outcomes.

Extracurricular Achievements

Dr. De Sa’s achievements in ultramarathoning showcase his discipline and resilience, qualities that translate well into the rigorous demands of research and clinical practice.

conclusion

Dr. Hong De Sa’s extensive training, leadership roles, research contributions, recognition, and commitment to service make him an outstanding candidate for the Women Researcher Award. His multifaceted approach to medicine and research aligns perfectly with the values and standards of this prestigious recognition.

Publication top notes

Novel Biomarkers and Molecular Targets in ALL

The impact of omidubicel on immune reconstitution and infections in cord blood transplant patients

 

 

Pedro de Marchi | Epidemiology | Academic Engagement Excellence Award

Dr. Pedro de Marchi | Epidemiology | Academic Engagement Excellence Award

Dr. Pedro de Marchi, ONCOCLINICAS, Brazil

Dr. Pedro de Marchi is a leading medical oncologist specializing in head and neck cancer at Oncoclรญnicas, Brazil. He serves as the National Leader and Medical Coordinator, alongside being a Professor of Medicine at Universidade Estadual do Rio de Janeiro. Dr. Marchi completed his MD at Universidade Federal de Santa Maria and furthered his training in internal medicine and oncology. His research focuses on the efficacy of immune checkpoint inhibitors and head and neck squamous cell carcinoma. Dr. Marchi has led several significant studies and has been involved in numerous conferences to advance cancer treatment. ๐ŸŽ—๏ธ๐Ÿ‘จโ€โš•๏ธ๐Ÿ“š

Publication Profile

Google Scholar

Education

Dr. Pedro de Marchi earned his MD from Universidade Federal de Santa Maria (UFSM) in 2008. He completed a residency in Internal Medicine at the Universidade Federal do Rio Grande do Sul and a Clinical Fellowship in Medical Oncology at Hospital Sรฃo Lucas (PUC-RS). He further enriched his expertise through an observership at The University of Texas MD Anderson Cancer Center. Dr. Marchi holds a Master’s in Oncology from Fundaรงรฃo Pio XII, focusing on chemotherapy toxicity in head and neck cancer, and a PhD in Oncology, studying immune checkpoint inhibitors and biomarkers in lung cancer. ๐ŸŽ“๐Ÿ’‰๐Ÿ“–

 

Experience and Service

Dr. Pedro de Marchi has an extensive career in oncology, serving as a resident at Universidade Federal do Rio Grande do Sul (2009-2011) and a Medical Oncology Fellow at Hospital Sรฃo Lucas (2011-2014). He was the Head of Thoracic and Head & Neck Oncology at Barretos Cancer Hospital (2016-2020) and is currently a National Leader in Head & Neck Cancer at Oncoclรญnicas. In addition, he coordinates multiple fellowship programs and serves as a Professor of Medicine at Universidade Estadual do Rio de Janeiro. His leadership roles reflect his commitment to advancing oncology care and research. ๐Ÿฉบ๐ŸŒŸ๐Ÿ“š

 

Honors and Awards

Dr. Pedro de Marchi was recognized with the AMRIGS Medical Qualification by the Medical Association of Rio Grande do Sul in Porto Alegre, Brazil, in 2008. This prestigious honor highlights his dedication to the medical field and his commitment to achieving excellence in healthcare. The award underscores his professional qualifications and serves as a testament to his skills as a medical practitioner. Dr. de Marchi’s achievements reflect his continuous pursuit of knowledge and his contribution to advancing medical practice in Brazil. ๐Ÿ†๐ŸŽ“๐ŸŒŸ

 

Research Contributions

Dr. Pedro de Marchi has made significant contributions to cancer research through various grants and contracts. As the Principal Investigator, he led studies on head and neck squamous cell carcinoma epidemiology and COVID-19 mortality determinants among cancer patients, securing substantial funding from notable organizations like MSD, AMGEN, and AstraZeneca. His research includes pivotal Phase III trials assessing innovative treatments for squamous cell carcinoma. These efforts not only advance medical knowledge but also aim to improve patient outcomes in Brazil. Dr. de Marchi’s work is essential in addressing critical health challenges in oncology. ๐Ÿ“Š๐Ÿ”ฌ๐ŸŽ—๏ธ

 

Teaching

Dr. Pedro de Marchi plays a vital role in medical education and mentorship. He serves as a Clinical Research Mentor in the Oncoclinicas Mentorship Programme since 2024, fostering the next generation of oncologists. As a Professor at Universidade Estadual do Rio de Janeiro (UERJ), he instructs rotating medical students, enhancing their clinical skills. Additionally, Dr. de Marchi supervises postdoctoral research fellows in Internal Medicine and Thoracic and Head & Neck Medical Oncology, guiding them in their academic and clinical pursuits. His commitment to education ensures that future physicians are well-equipped for the challenges of oncology. ๐Ÿ“š๐Ÿ‘จโ€โš•๏ธ๐ŸŽ“

 

Conclusion

Dr. Pedro de Marchi exemplifies the qualities sought after for the Research for Academic Engagement Excellence Award. His leadership in cancer research, dedication to education, and significant contributions to the field make him a suitable candidate for this prestigious recognition.

Publication Top Notes

  • Pembrolizumab versus chemotherapy for untreated PD-L1-expressing NSCLC (KEYNOTE-042) ๐ŸŒŸ โ€” Cited by: 3065, Year: 2019
  • Durvalumab plus platinumโ€“etoposide for extensive-stage SCLC (CASPIAN) ๐ŸŽฏ โ€” Cited by: 1679, Year: 2019
  • First-line nivolumab plus ipilimumab and chemotherapy in NSCLC (CheckMate 9LA) ๐Ÿš€ โ€” Cited by: 1086, Year: 2021
  • Durvalumab with/without tremelimumab for extensive-stage SCLC (CASPIAN) โš–๏ธ โ€” Cited by: 487, Year: 2021
  • CheckMate 9LA 2-year update: nivolumab plus ipilimumab and chemotherapy vs. chemotherapy alone ๐Ÿ•’ โ€” Cited by: 172, Year: 2021
  • Lung cancer in Brazil ๐Ÿ‡ง๐Ÿ‡ท โ€” Cited by: 142, Year: 2018
  • PD-L1 expression in NSCLC: TPS vs. CPS ๐Ÿงฌ โ€” Cited by: 77, Year: 2021
  • Cรขncer de pulmรฃo no Brasil ๐Ÿ“ˆ โ€” Cited by: 70, Year: 2018
  • MiR-21 as a prognostic biomarker in head and neck SCC ๐Ÿ“Š โ€” Cited by: 69, Year: 2017
  • Determinants of COVID-19 mortality in cancer patients in Brazil ๐Ÿฆ  โ€” Cited by: 50, Year: 2021

James Melrose | Health Professions | Best Researcher Award

Prof. James Melrose | Health Professions | Best Researcher Award

Prof. James Melrose, The University of Sydney, Australia

Based on the provided information, Prof. James Melrose appears to be a highly suitable candidate for the Research for Best Researcher Award. Hereโ€™s an evaluation of his qualifications:

Publication profile

Academic and Research Excellence

Prof. Melrose has a solid educational background with a B.Sc (Hons) in Biochemistry and a Ph.D. focused on carbohydrate metabolizing enzymes associated with barley. His long-standing affiliation with prestigious institutions such as The University of Sydney and the University of New South Wales highlights his strong academic and research credentials. Over a period of three decades, he has contributed significantly to bone and joint research, particularly in biochemical and immunological studies.

Special Awards and Recognitions

Prof. Melrose has received numerous prestigious awards throughout his career, demonstrating his recognition by the scientific community. Notable awards include the Smith and Nephew Award for his work on the spine, the Matrix Biology Society’s best poster award, and the European Spine Society’s GRAMMER Award. These accolades emphasize his contributions to the field of spine research and matrix biology, marking him as a leading researcher.

Teaching and Mentorship

Prof. Melrose has a strong background in teaching and mentorship, having served as a laboratory demonstrator, lecturer, and co-supervisor of Ph.D. students. His involvement in training and supervising research personnel at the Raymond Purves Bone and Joint Research Laboratories underscores his commitment to education and nurturing the next generation of researchers. This combination of research and teaching excellence enhances his candidacy for the award.

Publication Top Notes

  • ๐Ÿ“š “Are animal models useful for studying human disc disorders/degeneration?”
    • European Spine Journal 17, 2-19
    • Cited by: 854
    • Year: 2008
  • ๐Ÿ“˜ “Diverse cell signaling events modulated by perlecan”
    • Biochemistry 47 (43), 11174-11183
    • Cited by: 319
    • Year: 2008
  • ๐Ÿ”ฌ “Increased nerve and blood vessel ingrowth associated with proteoglycan depletion in an ovine anular lesion model of experimental disc degeneration”
    • Spine 27 (12), 1278-1285
    • Cited by: 255
    • Year: 2002
  • ๐Ÿงฌ “Proteoglycan degradation by the ADAMTS family of proteinases”
    • Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1812 (12)
    • Cited by: 249
    • Year: 2011
  • ๐Ÿ” “Keratan sulfate, a complex glycosaminoglycan with unique functional capability”
    • Glycobiology 28 (4), 182-206
    • Cited by: 226
    • Year: 2018
  • ๐Ÿฆด “Proteoglycan 4 downregulation in a sheep meniscectomy model of early osteoarthritis”
    • Arthritis research & therapy 8, 1-6
    • Cited by: 200
    • Year: 2006
  • ๐Ÿ’‰ “Not all perlecans are created equal: interactions with fibroblast growth factor (FGF) 2 and FGF receptors”
    • Journal of Biological Chemistry 277 (17), 14657-14665
    • Cited by: 200
    • Year: 2002
  • ๐Ÿ”— “A comparative analysis of the differential spatial and temporal distributions of the large (aggrecan, versican) and small (decorin, biglycan, fibromodulin) proteoglycans of theโ€ฆ”
    • The Journal of Anatomy 198 (1), 3-15
    • Cited by: 194
    • Year: 2001
  • ๐Ÿง  “Increased synthesis of matrix metalloproteinases by aortic smooth muscle cells is implicated in the etiopathogenesis of abdominal aortic aneurysms”
    • Journal of vascular surgery 24 (1), 82-92
    • Cited by: 173
    • Year: 1996
  • ๐Ÿ“ˆ “Comparative spatial and temporal localisation of perlecan, aggrecan and type I, II and IV collagen in the ovine meniscus: an ageing study”
    • Histochemistry and cell biology 124, 225-235
    • Cited by: 164
    • Year: 2005

Conclusion

Prof. James Melrose’s extensive research experience, numerous awards, and significant contributions to biochemistry and spine research make him a highly deserving candidate for the Research for Best Researcher Award. His roles in teaching and mentoring further solidify his position as a leader in his field, making a lasting impact on both research and education.

Naveen Khargekar | Public Health Award | Best Researcher Award

Dr. Naveen Khargekar | Public Health Award | Best Researcher Award

Dr. Naveen Khargekar, ICMR-National Institute of Immunohaematology, India

Based on Dr. Naveen Khargekar’s extensive qualifications and achievements, he appears to be a strong candidate for the Research for Best Researcher Award. Here’s a detailed evaluation:

Publication profile

Education

Dr. Khargekar holds an MD in Community Medicine from Topiwala National Medical College, Mumbai, with a thesis focused on protein energy malnutrition in tribal areas. He further specialized in Preventive Oncology through a fellowship at Homi Bhabha National Institute, Tata Memorial Center. His UICC Technical Fellowship provided individual mentorship in cervical cancer, enhancing his expertise in cancer prevention and treatment.

Employments

Dr. Khargekar’s career includes significant roles such as Scientist-E at ICMR-National Institute of Immunohaematology, Assistant Professor in Preventive Oncology at Tata Memorial Center, and Consultant & Coordinator at Sri Shankara Cancer Hospital. His work demonstrates a strong commitment to cancer research and community oncology.

Teaching Activities

Dr. Khargekar has been involved in various educational initiatives, including workshops on tobacco control, preventive oncology, and sickle cell disease. His contributions to CME programs and residential workshops highlight his dedication to training and capacity building in the field of community and preventive medicine.

Workshops and Seminars

Dr. Khargekar’s participation in numerous workshops and seminars, including those on research methodology, good clinical practices, and systematic reviews, reflects his commitment to staying updated with the latest advancements and methodologies in research and public health.

Publication Top Notes

  1. Knowledge, attitude, and practice about cervical cancer and its screening among community healthcare workers of Varanasi district, Uttar Pradesh, India
    D Khanna, N Khargekar, A Budukh
    Journal of Family Medicine and Primary Care 8 (5), 1715-1719
    Cited by: 68 (2019) ๐Ÿฉบ
  2. Compliance of cigarettes and other tobacco products act among tobacco vendors, educational institutions, and public places in Bengaluru City
    NC Khargekar, A Debnath, NR Khargekar, P Shetty, V Khargekar
    Indian Journal of Medical and Paediatric Oncology 39 (04), 463-466
    Cited by: 25 (2018) ๐Ÿšญ
  3. Immunization status of children under 5 years in a tribal area, Parol, Thane district
    NC Khargekar, VC Khargekar, PP Shingade
    National Journal of Community Medicine 6 (04), 522-527
    Cited by: 23 (2015) ๐Ÿ’‰
  4. Determinants of tobacco use and prevalence of oral precancerous lesions in cab drivers in Bengaluru City, India
    P Shetty, NC Khargekar, A Debnath, NR Khargekar, BK Srivastava
    International Journal of Preventive Medicine 8 (1), 100
    Cited by: 18 (2017) ๐Ÿšฌ
  5. Role of social support in tobacco cessation
    N Khargekar
    International Journal of Community Medicine and Public Health 4 (11), 3942
    Cited by: 15 (2017) ๐Ÿ’ช
  6. Implementation of early detection services for cancer in India during COVID-19 pandemic
    D Khanna, NC Khargekar, AK Khanna
    Cancer Control 27 (1), 1073274820960471
    Cited by: 12 (2020) ๐Ÿฆ 
  7. Cancer pattern in Varanasi district from Uttar Pradesh state of India, a foundation for cancer control based on the first report of the population-based cancer registry
    AM Budukh, S Pradhan, VB Singh, D Khanna, SS Bagal, PS Chakravarti
    Indian Journal of Cancer
    Cited by: 11 (2023) ๐ŸŽ—๏ธ
  8. A cross-sectional study to assess the protein energy malnutrition in children between one to five years of age in a tribal area Parol, Thane district, Maharashtra, India
    NC Khargekar, VC Khargekar, PP Shingade
    International Journal of Community Medical Public Health 3, 112-120
    Cited by: 8 (2016) ๐Ÿฝ๏ธ
  9. Cleft lip and palate-A psychology insight
    N Khargekar, N Khargekar, V Khargekar, S Rajan
    Sci Publ Group 5 (4), 37
    Cited by: 6 (2016) ๐Ÿ‘„
  10. Chronic Hepatitis B and Related Liver Diseases Are Associated with Reduced 25-Hydroxy-Vitamin D Levels: A Systematic Review and Meta-Analysis
    A Banerjee, S Athalye, N Khargekar, P Shingade, M Madkaikar
    Biomedicines 11 (1), 135
    Cited by: 5 (2023) ๐Ÿฆ 
  11. Role of hydroxyurea therapy in the prevention of organ damage in sickle cell disease: a systematic review and meta-analysis
    N Khargekar, A Banerjee, S Athalye, N Mahajan, N Kargutkar, P Tapase
    Systematic Reviews 13 (1), 60
    Cited by: 4 (2024) ๐Ÿ’Š
  12. Exploring risk factors and transmission dynamics of Hepatitis B infection among Indian families: Implications and perspective
    S Athalye, N Khargekar, S Shinde, T Parmar, S Chavan, G Swamidurai
    Journal of Infection and Public Health 16 (7), 1109-1114
    Cited by: 4 (2023) ๐Ÿฆ 
  13. A systematic review on hydroxyurea therapy for sickle cell disease in India
    A Pandey, H Kaur, S Borah, N Khargekar, VK Karra, T Adhikari, D Jain
    Indian Journal of Medical Research 156 (2), 299-311
    Cited by: 4 (2022) ๐Ÿ’‰
  14. A cross sectional assessment of the profile of risk factors of non-communicable diseases among health care staff of a tertiary cancer hospital
    N Khargekar, A Singh, T Shruti, S Pradhan
    Journal of Lifestyle Medicine 12 (2), 98
    Cited by: 4 (2022) ๐Ÿฅ
  15. Comparative study of clinical features and vaccination status in Omicron and non-Omicron infected patients during the third wave in Mumbai, India
    A Takke, M Zarekar, V Muthuraman, A Ashar, K Patil, A Badhavkar
    Journal of Family Medicine and Primary Care 11 (10), 6135-6142
    Cited by: 3 (2022) ๐Ÿฆ 
  16. Is it possible to reduce cancer burden in India
    N Khargekar, V Khargekar, HG Srivatsa, N Khargekar
    J Med Sci Clin Res 5, 19837-44
    Cited by: 3 (2017) ๐Ÿ‡ฎ๐Ÿ‡ณ
  17. Cancer Screening during COVID-19 Pandemic
    NC Khargekar, D Khanna
    Asia-Pacific Journal of Oncology Nursing 7 (4), 308-309
    Cited by: 2 (2020) ๐Ÿฆ 
  18. Exploring factors influencing the perspective regarding HIV transmission and prevention among college students in India
    N Khargekar, A Takke, S Athalye, P Panale, N Rajamani, A Banerjee
    Journal of Family Medicine and Primary Care 13 (4), 1467-1472
    Cited by: 1 (2024) ๐Ÿงฌ
  19. Impact of COVID-19 infection among Indian sickle cell disease patients
    N Khargekar, N Shinde, A Banerjee, M Madkaikar, A Nadkarni
    Indian Journal of Public Health 67 (1), 112-116
    Cited by: 1 (2023) ๐Ÿฆ 
  20. Epidemiological study of adverse events following immunization in under 5 year children
    VS Pagar, SS Chavan, SP Patil, A Borde, AD Kinge, N Khargekar
    Journal of Family Medicine and Primary Care 10 (7), 2482-2487
    Cited by: 1 (2021) ๐Ÿ’‰

Conferences and Presentations

He has actively participated in national and international conferences, presenting papers on topics such as cancer screening compliance and hematological parameters in sickle cell anemia patients. His engagement in these forums demonstrates his active role in advancing medical knowledge and practices.

Achievements

Dr. Khargekar is a member of several institutional committees, including ethics and biosafety committees, which indicates his involvement in maintaining high standards of research ethics and safety.

Conclusion

Dr. Naveen Khargekar’s extensive education, diverse experience, active involvement in teaching and research, and significant contributions to peer-reviewed literature position him as a highly suitable candidate for the Research for Best Researcher Award. His work in preventive oncology and public health aligns well with the criteria for this prestigious award.